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Osteochondral injuries remain difficult to repair. We developed a novel photo-cross-linkable
furfurylamine-conjugated gelatin (gelatin-FA). Gelatin-FA was rapidly cross-linked by visible light with
Rose Bengal, a light sensitizer, and was kept gelled for 3 weeks submerged in saline at 376C. When bone
marrow-derived stromal cells (BMSCs) were suspended in gelatin-FA with 0.05% Rose Bengal,
approximately 87% of the cells were viable in the hydrogel at 24 h after photo-cross-linking, and the
chondrogenic differentiation of BMSCs was maintained for up to 3 weeks. BMP4 fusion protein with a
collagen binding domain (CBD) was retained in the hydrogels at higher levels than unmodified BMP4.
Gelatin-FA was subsequently employed as a scaffold for BMSCs and CBD-BMP4 in a rabbit osteochondral
defect model. In both cases, the defect was repaired with articular cartilage-like tissue and regenerated
subchondral bone. This novel, photo-cross-linkable gelatin appears to be a promising scaffold for the
treatment of osteochondral injury.
M
anagement and repair of osteochondral injuries in the knee remain challenging. Osteochondral
injuries involve damage to both the articular cartilage and the underlying subchondral bone.
Articular cartilage (hyaline cartilage) has limited intrinsic healing capabilities. Once injured, lesions
are typically replaced by fibrocartilage, a scar tissue with different biomechanical properties and impaired
mechanical function1,2. Covering the load-bearing surfaces of joint bones with fibrocartilage fails to protect
the subchondral bone from further degeneration. As osteochondral defects are often associated with joint
mechanical instability, the potential problems after osteochondral injury include early osteoarthritis and/or
osteoarthrosis (OA)3. The goals for treatment of osteochondral injuries are to restore hyaline cartilage and
subchondral bone regeneration.
Over the last few decades, progress has beenmade using surgical repair interventions. Recent advances in these
treatment methods include the use of tissue specific cells, progenitor cells, and appropriate cellular stimulation
with growth factors at the affected sites4,5. Currently, tissue-engineering approaches using scaffold-based proce-
dures have been attracting increasing attention6. A scaffold provides an environment for cell attachment, pro-
liferation, and differentiation. In addition, scaffolds can be used to achieve drug delivery with high-loading
efficiency at specific sites. Biologic scaffolds employed to date as natural polymers include alginate, collagen,
fibrin, albumin, hyaluronan, platelet-rich plasma, and gelatin7.
Gelatin is a very promising material for cell proliferation and tissue regeneration, but has the disadvantage of
mechanical weakness. Recently, chemical modification of gelatin has been reported to improve its mechanical
properties by cross-linking with visible light8–12. Photo-induced cross-linking or polymerization is a fast and
convenient way to produce gels or high-molecular-weight polymers. The scaffold can be formed at specific sites
using injectable solutions and visible light, making the application to a designated site simple and minimally
invasive. We have previously developed a new type of gelatin by incorporating furfuryl isocyanate (gelatin-FI),
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which was photo-cross-linked with Rose Bengal (RB), a food dye.
The photo-crosslinkable gelatin-FI was useful as a direct pulp cap-
ping material in the dental field13.
Tissue cells feel and respond to the stiffness of their substrate14.
The physical properties of scaffold influence cell function and tissue
morphogenesis15. Consequently, physical characteristics must be
considered when designing hydrogels for tissue-engineering applica-
tions16. It was found that the stiffness of the hydrogel strongly affec-
ted the cell attachment, focal adhesion, migration and proliferation17.
Here, we developed another new gelatin derivative that was modified
with furfurylamine (gelatin-FA). Gelatin-FA was consolidated by
visible light more rapidly with stiffer properties than gelatin-FI in
the presence of RB. In the present study, we demonstrate that this
novel modified gelatin-FA is an effective scaffold for osteochondral
repair in a rabbit osteochondral defect model. Gelatin-FA hydrogels
were used to deliver bone marrow stromal cells (BMSCs) and bone
morphogenetic protein-4 (BMP4) with collagen binding domains
(CBD) to the affected sites. The results suggest that this modified
gelatin, in combination with cells and collagen-binding growth fac-
tors, is a promising scaffold for tissue engineering because uniform
cell seeding is easy to achieve; the implanted cells survive and differ-
entiate; and growth factor(s) with CBD are retained in the hydrogel.
Results
Properties of gelatin-FA. After visible light irradiation, the mixture
was transformed from solution to gel by a photo-oxidation cross-
linking (POC) mechanism. The chemistry of gelatin-FA is shown in
Fig. 1a. By utilizing the carboxy groups in the gelatin for coupling
with furan, the remained amino groups in the gelatin were expected
to contribute the adhesiveness and stiffness after crosslinking. The
1H-NMR spectra of gelatin before and after furfurylamine conju-
gation are shown in Figure 1b. In unconjugated gelatin, there was a
broad peak at 7.25 ppm, contributed mostly by the benzene proton
of phenylalanine residues. In addition to this peak, gelatin-FA and
gelatin-FI had three new peaks found at 6.1, 6.2, and 7.3 ppm,
attributed to the furan group. The approximate composition of
aromatic amino acids in porcine gelatin is 2%, which is similar to
the estimate for furan groups in gelatin-FA (2.9%) based on the peak
area in 1H-NMR spectra. To compare gelatin-FAwith our previously
reported gelatin-FI13, 10% aqueous solutions of gelatin-FA and
gelatin-FI were mixed with RB (0.5%) on a plate and illuminated
for 10, 30, 60, and 180 s by visible light. The plate was washed to
remove uncross-linked solutions and the gelation rate was observed.
As shown in Figure 1c, approximately 75% of gelatin-FA formed a
hydrogel after 30 s of illumination. Conversely, gelatin-FI remained
a solution after 60 s of illumination, and only 15% was gelled after
180 s of illumination, indicating that gelatin-FA has more rapid
cross-linking.
Next, the rheological properties of the modified gelatin were
examined after illumination with visible light. Both the storage
(G9) and loss (G0) moduli of gelatin-FA hydrogels were higher than
themoduli of gelatin-FI hydrogels, suggesting that gelatin-FA hydro-
gels had higher elasticity and flexibility (Fig. 2). It has demonstrated
that hydrogel with higher G9 showed significantly up-regulated
expressions of osteocalcin and runt-related transcription factor 2
(RUNX2), with the presence of alkaline phosphatase, and the evid-
ence of calcium accumulation15. Meanwhile, the G0/G9 (equivalent to
tan d) ratio of gelatin-FA hydrogels was relatively low, indicating a
Figure 1 | Properties of modified gelatin. (a) Synthetic scheme of modified gelatin and the cross-linking mechanism. (b) 1H-NMR spectra of gelatin in
D2O before and after modification. (c) Time course of gel formation of furfuryl-conjugated gelatin (gelatin-FA and gelatin-FI, each 10%) with Rose
Bengal (0.5%) after visible light illumination.
www.nature.com/scientificreports
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low viscosity similar to gelatin-FI hydrogels (Fig. 2). These data
suggest that gelatin-FA has better appropriate physical properties
relative to gelatin-FI.
Cytotoxicity and phototoxicity. The RB cytotoxicity and phototo-
xicity toward BMSCs were investigated. The data assessed at 24 h
were shown in Figure 3a. RB was cytotoxic to more than 70% of the
cells at 1% RB. At 0.1% RB, the percentage of viable cells was
significantly improved in the presence of gelatin-FA, indicating a
cytoprotection function of gelatin-FA. Gelatin-FA also reduced the
phototoxicity by visible light at 0.1% and 0.01% RB concentrations
(Fig. 3a). BMSCs in gelatin-FA were kept alive at the same level for 7
days at 0.01% RB with or without light illumination. Even at a higher
concentration of RB (0.1%), about 50% BMSCs were alive in gelatin-
FA after 7 days whereas all of the cells were dead without gelatin-FA
(Fig. 3b). Next, the photo-cross-linkable intensity was examined. To
do this, gelatin-FA (15%) with various concentrations of RB (0.005,
0.01, 0.05, 0.1%) was submerged in PBS, and exposed to visible light
for 2 min. Gelatin-FA hydrogels with 0.05% RB were macrosco-
pically unchanged in PBS for at least 21 days at 37uC (Fig. 3c). RB
concentrations below 0.01% failed to form solid gels in the
submerged conditions (not shown). The viability of cells in gelatin-
FA hydrogels with 0.05% RBwas 87.3% on day 1, 55.8% on day 3 and
44.1% on day 7 after light exposure in the submerged conditions
(Fig. 3d). The percent viable cells at 24 h in 0.05% RB was larger
than those in 0.1% RB (64.0% viable, Fig. 3a). Thus, 0.05% RB was
chosen as a suitable concentration for cell-based scaffolds. When
BMSCs were cultured in the gelatin-FA hydrogels, DNA and acidic
mucopolysaccharide contents were measured. Although the DNA
content in the hydrogels decreased with time, the acidic mucopoly-
saccharide level was unchanged throughout the observation period.
The resulting acidic mucopolysaccharide-to-DNA ratio, reflecting
chondrogenic differentiation of BMSCs, increased with time for up
to 3 weeks, suggesting that BMSCs differentiated into chondrocytes
in the gelatin-FA scaffold (Fig. 3e).
Gelatin-FA as a scaffold for BMSC implantation. To examine
whether gelatin-FA could be useful for tissue engineering, we first
employed it as a scaffold for BMSCs. BMSCs (1.5 3 105 cells) were
suspended in 15% gelation-FA containing 0.05% RB, and the mix-
tures were implanted into rabbit osteochondral defects and exposed
to visible light for 2 min (Fig. 4a). Four weeks later, the defect lesion
was filled with regenerated tissues (Fig. 4b). No meaningful diffe-
rences were found in gelatin-FA-treated groups as compared with
the untreated controls at this time point. At 12 weeks, the defect
lesion showed degenerative changes in the untreated group. Regene-
rative tissue filled the defect in the gelatin-FA group, although the
surface appeared roughened. In the gelatin-FA plus BMSCs group,
the articular surface appeared to be similar to the surrounding intact
cartilage (Fig. 4b). The gross grading score demonstrated an
improvement in defects after the treatment with gelatin-FA plus
BMSCs. Gelatin-FA by itself also improved the repair (Fig. 4c).
Histologically, untreated osteochondral defects were not covered
with regenerative tissues. Gelatin-FA-treatment allowed granula-
tion tissue to fill the defect at 4 weeks (Fig. 4d). Macrophages were
evident in the granulation tissue in gelatin-FA-treatment, which
were more prominent in gelatin-FA plus BMSCs (Fig. 4e). Hyaline
cartilage-like cells were seen at 12 weeks with their surrounding
matrix stained with safranin O (Fig. 4d). The stained area in
repaired lesions was significantly larger in the gelatin-FA plus
BMSCs group as compared with the gelatin-FA group (Table 1).
Histological grading scores at 4 and 12 weeks after surgery re-
vealed that treatment with gelatin-FA plus BMSCs improved tissue
regeneration (Fig. 4f). The score at 12 weeks was significantly higher
than at 4 weeks (P , 0.01, by Mann–Whitney U test). Gelatin-FA
without BMSCs also showed an improved repair compared with
untreated controls (Fig. 4f). Type II collagen, not found in
untreated groups, was present in the gelatin-FA alone and gelatin-
FA plus BMSCs groups, and the staining was more intense in the
gelatin-FA plus BMSCs group (Fig. 4g). Likewise, aggrecan was not
found in untreated groups but stained in gelatin-FA plus BMSCs
Figure 2 | Storage (G9) and loss (G0) moduli of gelatin-FA and gelatin-FI hydrogels (10%) at 376C cross-linked by visible light in the presence of Rose
Bengal (0.5%).
www.nature.com/scientificreports
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group (Fig. 4h). Subchondral bone repair was found in the gelatin-FA
plus BMSCs group (Fig. 5a). The BV/TV value was significantly
higher after treatment with gelatin-FA plus BMSCs than in the
other groups (Fig. 5b). All these findings support this modified
gelatin-FA as a useful cell scaffold for the treatment of osteo-
chondral defects.
Gelatin-FA as a scaffold for growth factors.We then asked whether
gelatin-FA could be used as a scaffold for growth factor-based tissue
engineering. We used BMP4 and CBD-BMP4 as growth factors.
CBD-BMP4 exhibited stronger and more stable collagen binding
activity than did wild-type BMP413,18. Because gelatin is a hydro-
lyzed form of collagen, we hypothesized that CBD-BMP4 may be
better retained in gelatin-FA hydrogels than native BMP4. To test
this, BMP4 and CBD-BMP4 (380 nM) were suspended in separate
gelatin solutions (15% gelatin-FA and 0.05% RB), photo-cross-
linked by visible light, and then cultured in PBS for 7 days. The
supernatants were collected and BMP4 concentrations measured
by ELISA. As shown in Table 2, BMP4 was rapidly released from
gelatin-FA hydrogels, whereas CBD-BMP4 was retained in the
hydrogels for at least 7 days.
We next implanted BMP4- or CBD-BMP4-containing gelatin
solutions (15% gelatin-FA and 0.05% RB) into osteochondral bone
defects and exposed them to visible light for 2 min. Growth factor-
loaded gelatin-FA hydrogels facilitated cartilage repair (Fig. 6a–d). In
particular, CBD-BMP4-loaded gelatin-FA showed complete filling of
the defect with a tissue that resembled the surrounding normal hyal-
ine cartilage at 12 weeks (Fig. 6a). Repair tissue in the defects treated
Figure 3 | Cytotoxicity and phototoxicity. (a) BMSCs (5 3 103 cells) were cultured in gelatin-FA (15%) and various concentrations of RB (0.01, 0.1, and
1%) and gelled by illumination with visible light for 2 min. After 24 h, the % cell viability was determined. *P , 0.05, **P , 0.001, vs. RB 1 light
illumination (5wells each,Mann–WhitneyU test). (b) BMSCs (53 103 cells) were cultured in gelatin-FA (15%) plus RB (0.01 or 0.1%). The%viable cells
were monitored at 24 h, 72 h and on day 7 after light illumination with visible light for 2 min. Open circle; RB only, closed circle; RB 1 gelatin-FA, open
square; RB 1 light illumination, closed square; RB 1 gelatin-FA 1 light illumination (5 well each). (c) Gelatin-FA (15%) with 0.05% RB was submerged
in PBS, and exposed to visible light for 2 min, after which the hydrogels were observed for 21 days at 37uC. Representative photographs (5 wells each) are
shown. (d) BMSCs (5 3 103 cells) were suspended in gelatin-FA (15%) with 0.05% RB, submerged in PBS, and exposed to visible light for 2 min, after
which the hydrogels were observed for 7 days at 37uC. The percent viable cells in the hydrogels were examined at indicated time-points after the light
illumination (5 wells each). (e) BMSCs (5 3 104 cells) were suspended in gelatin-FA (15%) and 0.05% RB, submerged in PBS, and gelled by illumination
with visible light for 2 min. DNA and acidic mucopolysaccharide contents in the gelatin-FA hydrogels were measured at indicated time-points. The
resultant acidic mucopolysaccharide-to-DNA ratio was then calculated (5 wells each).
www.nature.com/scientificreports
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with CBD-BMP4-loaded gelatin-FAwas strongly stained by safranin
O, suggesting the presence of sufficient proteoglycans in the repaired
tissue (Fig. 6c). Gross and histological scores showed that CBD-
BMP4 led to more cartilage repair than did BMP4. Tissue repair by
gelatin-FA itself demonstrated some improvement compared with
the untreated group at 12 weeks (Fig. 6b, d). To investigate the
molecular mechanisms of repair, the regenerated tissues were har-
vested at 4 weeks after surgery and the mRNA expression of several
chondrogenic factors were examined. SOX9, aggrecan, col1a1, and
col2a1 were all expressed at higher levels in the CBD-BMP4-gelatin-
FA group than in the other groups, including the BMP4 group
(Fig. 6e). Thus, the superior cartilage repair in the CBD-BMP4 group
Figure 4 | Gelatin-FA as a cell scaffold in an osteochondral defect model. BMSCs (1.5 3 105 cells) were suspended in gelatin solution (15% gelation-FA
1 0.05% RB), implanted into osteochondral defects, and exposed to visible light for 2 min. (a) Schematic illustration of the operative procedure.
(b) Gross appearance after the procedure. Representative photographs (six femurs each). (c) Gross grading scores at 4 and 12 weeks after the surgery.
*P, 0.05, **P, 0.01, ***P, 0.001 (six femurs each). (d) Representative safranin O staining photos at 4 and 12 weeks are shown (six femurs each). The
scale bar indicates 500 mm. (e) Representative macrophage staining photos at 4 weeks are shown (six femurs each). The scale bar indicates 200 mm.
(f) Histological grading scores at 4 and 12 weeks. *P , 0.05, **P , 0.01, ***P , 0.001 (six femurs each). (g, h) Representative type II collagen
immunostaining (g) and aggrecan staining (h) at 12 weeks after the surgery are shown (six femurs each). The scale bar indicates 500 mm (g) and
200 mm (h).
Table 1 | Evaluation of safranin O staining
Safranin O stain % Safranin O in defect
defect 0.7 6 0.2 0.8 6 0.3
Gelatin-FA 1.4 6 0.2* 1.4 6 0.2
Gelatin-FA 1
BMSCs
2.2 6 0.1*, ** 2.6 6 0.2**, ***
Safrain O stain was evaluated by a grading scheme31.
*P , 0.05,
**P , 0.001 vs. defect.
***P , 0.01 vs. gelatin-FA.
www.nature.com/scientificreports
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was associated with increased expressions of chondrogenic factors.
The BMP4 group failed to increase the expression of these factors at 4
weeks after the surgery, possibly owing to its loss from the hydrogel.
Furthermore, CBD-BMP4-loaded gelatin-FA prompted subchon-
dral bone repair (Fig. 7a). The BV/TV value was significantly higher
after CBD-BMP4-gelatin-FA treatment thanwith the other groups at
12 weeks after surgery (Fig. 7b). Therefore, this modified gelatin-FA
was also useful as a scaffold for growth factor-based tissue
engineering.
Discussion
Scaffolds ideally need to be biocompatible, biodegradable, durable,
and capable of being formed into desired shapes. The novel modi-
fied gelatin-FA developed in the present study appears to be a
suitable biomaterial scaffold. Compared with our previously
reported gelatin-FI, gelatin-FA is more rapidly cross-linked in the
presence of RB by visible-light illumination. Such a rapid consol-
idation is suitable for clinical use. In addition, gelatin-FA has higher
elasticity and flexibility than gelatin-FI, with an equivalent viscosity.
These superior properties prompted us to examine the potential of
gelatin-FA for use in scaffold-based tissue engineering. By combin-
ing gelatin-FA with BMSCs and CBD-BMP4, we demonstrated that
photo-cross-linkable gelatin-FA is a promising scaffold for osteo-
chondral repair because it promotes production of a reparative
matrix.
Clinical trials have reported the safety and therapeutic effects of
BMSCs administration in patients with OA19. The clinical outcomes
after treatment with autologous BMSCs were as good as or better
than after autologous chondrocyte implantation20. Chondrocyte dif-
ferentiation from BMSCs in vitro using growth factors requires sig-
nificant time and expense, and subsequent engineered chondrocytes
do not fully maintain their chondrogenic properties after in vivo
transplantation21. Therefore, employing BMSCs is a reasonable
approach for the treatment of osteochondral injuries. One key point
when using BMSCs for osteochondral repair is to use an efficient
delivery system to localize the cells within a lesion without inhibiting
the influx of repair cells from the surrounding tissues. BMSCs are
mixtures of autologously acquired pluripotent cells withmultilineage
differentiation and high proliferation potentials, allowing for their
differentiation into osteogenic and chondrogenic lineages22. Studies
have demonstrated that the severe anaerobic environment in the
joint is efficient for the phenotypic expression of chondrocytes23,24.
Maintaining hydration and the anaerobic environment in gelatin-FA
hydrogels may stimulate the chondrogenic differentiation of BMSCs.
Here, we showed that transplanted BMSCs preserve their chon-
drogenic differentiation capability in our gelatin-FA scaffold, as
determined by the acidic mucopolysaccharide-to-DNA ratio. Alter-
natively, it is likely that BMSCs also attract host-derived mesenchy-
mal progenitor cells from the subchondral marrow or the adjacent
synovium via the release of various cytokines19, which in turn may
facilitate osteochondral tissue repair. We demonstrated that regen-
erated tissue by gelatin-FA plus BMSCs treatment contained more
macrophages relative to that by gelatin-FA alone. Further studies are
necessary to address the relative contributions of these mechanisms.
The use of growth factors with tissue engineering techniques is
another promising therapeutic strategy. To increase the therapeutic
potency of gelatin-FA, we employed CBD-BMP4 as a growth factor.
CBD-BMP4 is a novel fusion protein that is retained longer than
native BMP4 in tissues consisting of collagen, and exhibits an exquis-
ite ability to promote in vivo osteogenesis18. BMP4 is capable of
inducing osteogenic, as well as chondrogenic, differentiation25,26.
Because CBD-BMP4 is retained longer in gelatin-FA hydrogels, we
expected it to foster tissue repair. Although both gelatin-FA alone
and BMP4-gelatin-FA enhanced tissue repair to some degree, CBD-
BMP4-gelatin-FA produced a markedly improved osteochondral
repair. During this process, gelatin-FA covering the defect may
enhance the integration between the regenerated tissue and the sur-
rounding tissue, supporting tissue repair. The accelerated tissue
repair byCBD-BMP4-gelatin-FA appears to be based on endogenous
chondrogenic factors expressed by infiltrating cells from the sur-
rounding tissues. SOX9 is a key transcription factor for chondrogen-
esis27. SOX9 activates genes expressed in proliferating chondrocytes
that includes aggrecan28, one of the major structural components of
articular cartilage. Col1a1 and col2a1 encode for the major com-
ponents of collagen types I and II, respectively. The increased
expression of these genes in the CBD-BMP4 group suggested that
CBD-BMP4 tethering in the hydrogels contributed to the improved
tissue repair.
Figure 5 | Micro-computed tomography (CT) analysis at 12 weeks after
BMSCs implantation. (a) Representative three-dimensional-CT images
from each group (six femurs each) are shown. (b) Bone growth was
assessed by bone volume (BV) per tissue volume (TV). *P , 0.05,
**P , 0.01 (six femurs each).
Table 2 | Release of BMP4 and CBD-BMP4 from gelatin-FA hydrogels
day1 day 3 day 5 day 7
BMP4 1.23 6 0.10 1.03 6 0.05 0.99 6 0.07 0.96 6 0.06
CBD-BMP4 0.26 6 0.02* 0.23 6 0.01* 0.23 6 0.00* 0.21 6 0.01*
Culture supernatants from BMP4 or CBD-BMP4 containing gelatin-FA hydrogels were measured for BMP4. Data are OD at 490 nm.
*P , 0.05 vs. BMP4 (4 well each, Mann–Whitney U test).
www.nature.com/scientificreports
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Figure 6 | Gelatin-FA as a growth-factor scaffold in an osteochondral defect model. BMP4 or CBD-BMP4 (each 250 nM) was mixed into 15%
gelatin-FA containing 0.05% RB, and the mixtures were implanted into osteochondral bone defects and exposed to visible light for 2 min. (a)
Representative photographs of the gross appearance after the procedure (five femurs each). (b) Gross grading scores at 4 and 12 weeks after the procedure
(five femurs each). (c) Representative images of safraninO staining (five femurs each). The scale bar indicates 500 mm. (d)Histological grading scores at 4
and 12 weeks (five femurs each). (e) The expression levels of chondrogenic factors at 4 weeks (5 femurs each). *P , 0.05, **P , 0.01, ***P , 0.001
(five femurs each). ****P , 0.05, vs. untreated control (five femurs each, Mann–Whitney U Test).
www.nature.com/scientificreports
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There are other several concerns that were not addressed in this
study. Although we succeeded in producing hyaline-like differen-
tiated tissue that integrated with the surrounding native cartilage
at 12 weeks after the surgery under full weight bearing without any
joint immobilization, the physiological and mechanical properties of
the repaired tissue remain to be investigated. Longer-term obser-
vation is also necessary. It appears that the transplanted BMSCs
not only function as repair cells, but also stimulate the surrounding
tissues towards repair. However, the origin of the cells present at the
repair site, whether they are the originally transplanted BMSCs or
host cells that havemigrated to the defect, remains unknown. BMSCs
may escape from gelatin-FA hydrogels and move into the surround-
ing tissues. Although clinical trials have reported the safety of
BMSCs19, the multi-potent properties may be potential threats for
teratoma/tumorgenesis for a long term. How gelatin-FA hydrogels
support tissue repair and when gelatin-FA hydrogels are absorbed
and replaced by regenerated tissue is also unclear. We showed that
macrophages were present in the regenerated tissue after gelatin-FA
treatment. Macrophages are essential to would healing by their inter-
actions with other cellular populations and releasing growth fac-
tors29, suggesting that macrophages in the gelatin-FA scaffold
facilitate the tissue repair. An interesting question is whether a com-
bination strategy with BMSCs and CBD-BMP4 could increase the
regenerative potential of the scaffold, generating an additive or syn-
ergistic effect. Further studies are necessary to address these
possibilities.
In conclusion, we have developed photo-cross-linkable furfury-
lamine-conjugated gelatin. With this modified gelatin-FA, tissue-
engineering approaches that deliver BMSCs and CBD-BMP4 have
been evaluated in a rabbit osteochondral defect model. The results
in this study demonstrated that this novel gelatin-FA is useful for
cell-based, as well as growth factor-based, scaffolds. Gelatin is a
biocompatible, biodegradable and maneuverable material with no
harmful effects. Treatment strategies using photo-cross-linkable
gelatin-FA could be beneficial for the treatment of osteochondral
injuries.
Methods
Materials. Porcine skin gelatin (G2500), furfurylamine (FA), furfuryl isocyanate (FI),
deuterium oxide (D2O), and Rose Bengal (RB) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide
hydrochloride (EDC) and 2-morpholinoethanesulfonic acid monohydrate (MES)
were purchased from Dojindo Molecular Technologies, Inc. (Kumamoto, Japan). N-
hydroxysuccinimide (NHS) was purchased from Wako Pure Chemical Industries
(Osaka, Japan). Recombinant mouse BMP4, affinity purified anti-mouse BMP4
polyclonal IgG, and biotinylated anti-mouse BMP4 IgG were purchased from R&D
Systems (Minneapolis, MN, USA). CBD-BMP4 fusion protein was prepared as
described previously13.
Synthesis of furfuryl conjugated gelatin. Gelatin (5.0 g) was dissolved in 250 mL
MES buffer (50 mM, pH 5.0) at 40uC. Subsequently, 1.533 g (8 mmol) EDC, 0.806 g
(7 mmol) NHS, and 2.68 g (28 mmol) FA were added, and the solution was
maintained at 40uC for 24 h. The solution was then dialyzed using a dialysis
membrane (molecular weight cut off: 3,500 Da) for 2 days at 40uC. The FA-
conjugated gelatin was obtained by lyophilization and referred to as gelatin-FA.
Gelatin coupled with furfuryl isocyanate (gelatin-FI) was prepared, as previously
reported13. The structure of modified gelatin was characterized using nuclear
magnetic resonance spectroscopy (NMR). The samples were dissolved in D2O, and
the measurement performed using a JNM-AL300 spectrometer (JASCO
International Co., Tokyo, Japan).
Visible light induced cross-linking and formation of hydrogels. An aqueous
solution of gelatin-FA was mixed with an equal volume of RB. After illuminating for
2 min with visible light from a lamp (Luminar Ace LA-HDF158A, Hayashi Watch-
works Co., Tokyo, Japan), the mixture was transformed from a solution to a hydrogel
through photo-oxidation cross-linking, as illustrated in Figure 1A. Rheological
experiments were carried out with an ARES-G2 rheometer (TA instruments, New
Castle, DE,USA) using the parallel plates (25-mmdiameter, 0u) configuration at 37uC
in the oscillatory mode. The evolution of the storage (G9) and loss (G0) moduli were
recorded as a function of time at a frequency of 1 Hz and a strain of 1%.
Animals. Female NewZealand white rabbits weighing 2.0–2.5 kgwere obtained from
Shimizu Laboratory Supplies (Kyoto, Japan). Animals were housed in a temperature-
controlled environment with a 12-h light/12-h dark cycle and allowed free access to
water and food. The animal care and use committee at OkayamaUniversity approved
all animal experiments conducted in this study. All methods were carried out in
accordance with the approved guidelines.
Bone marrow stromal cells (BMSCs). BMSCs were purified as described
previously30. In brief, bonemarrow cells were aspirated from the humerus, femur, and
tibia of 5 rabbits. The cells were centrifuged and washed twice with phosphate-
buffered saline (PBS, pH 7.4). The cells were suspended in low-glucose Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS)
and antibiotics and cultured overnight in 100 mm 3 20 mm dishes at 37uC in a
humidified incubator with 5% CO2. Unattached cells were removed and the medium
was replaced every 3 days until the cells reached 80% confluence. Colonies formed
cells were detached with 0.25% trypsin-EDTA solution, washed twice with medium,
and divided into two dishes. Cells at passages two to three were used as BMSCs. Under
appropriate culture conditions, differentiation assays were performed to confirm cell
differentiation into chondrogenic and osteogenic lineages (not shown). The cells were
routinely alive more than 97% by trypan blue exclusion.
Cytotoxicity and phototoxicity. RB toxicity and phototoxic effects were examined
using BMSCs. BMSCs (5 3 103 cells) were incubated in a 96-well plate at 37uC in a
CO2 incubator for 24 h. Gelatin-FA (15%) and RB (0.01, 0.1, and 1%) were added to
the DMEM with 1% FBS and gelled by illumination with visible light for 2 min and
cultured for 24 h. In other set of experiments, Gelatin-FA (15%) was gelled with RB
(0.01 and 0.1%) and exposed to visible light for 2 min, and cultured for 24, 72 h and 7
days. Each well was washed three times with PBS and medium was added. The cell
proliferation reagent WST-1 (Roche Diagnostics, Indianapolis, IN) was used to
determine the number of viable cells according to the manufacturer’s instructions.
The cell numbers in wells without RBwere defined as the controls for each group, and
the number of cells in each well was normalized to its control to give % viability.
Cell evaluation in the gelatin-hydrogel. BMSCs (5 3 104 cells) were suspended in
culture medium (DMEM and 10% FBS) containing 15% gelatin-FA and 0.05% RB.
The mixture was cross-linked by visible light illumination for 2 min. The hydrogels
were incubated in a culture medium, and the medium was replaced every 3 days. On
days 1, 7, 14, and 21, the hydrogels were washed twice with PBS and sonicated in
100 mL extraction buffer. The DNA content and acidic mucopolysaccharide content
in the hydrogels were determined using DNA Quantity kits (Primary cell Co.,
Figure 7 | Micro-computed tomography (CT) analysis at 12 weeks
after BMP4 or CBD-BMP4 implantation. (a) Representative three-
dimensional-CT images from each group (five femurs each). (b) Bone
growth was assessed by bone volume (BV) per tissue volume (TV).
*P , 0.05, **P , 0.01, ***P , 0.001 (five femurs each).
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Hokkaido, Japan) and acidic mucopolysaccharide assay kits (Primary cell Co.),
according to the manufacturers’ instructions.
Osteochondral defect model. Rabbits were anesthetized with ketamine (1 mg/kg)
and isoflurane (0.25–5 L/min). Cylindrical osteochondral defects were made
bilaterally at the center of the medial femoral condyle with a 3.0-mm diameter
drill to a depth of 3.0 mm. Forty microliters of gelatin solution (15% gelatin-FA
and 0.05% RB) with or without BMSCs or growth factors was applied to the
defects and cross-linked with visible light for 2 min. BMP4 and CBD-BMP4 were
employed as growth factors. The defects untreated were used as controls. The
rabbits employed in BMSCs transplantation model were 18 rabbits (36 femurs:
defect control; 6 femurs 3 2 time points (4 weeks and 12 weeks), gelatin-FA; 6
femurs 3 2, gelatin-FA 1 BMSCs; 6 femurs 3 2). For growth factor
transplantation, 20 rabbits were used (40 femurs: defect control; 5 femurs 3 2
time points (4 weeks and 12 weeks), gelatin-FA; 5 femurs 3 2, gelatin-FA 1
BMP4; 5 femurs 3 2, gelatin-FA 1 CBD-BMP4; 5 femurs 3 2). The femurs were
treated at random. The joint capsule and the skin were closed in layers with 5-0
nylon sutures. The rabbits were allowed full weight bearing without any joint
immobilization. Rabbits were sacrificed at 4 and 12 weeks after the surgery, and
the lesion was assessed by a gross grading scheme31. In brief, the defect lesion was
scored based on four categories, each on a scale of 0–4 (best score: 16): coverage,
neocartilage color, defect margins, and surface. The femoral condyle was then
resected and scanned by microcomputed tomography (micro-CT; Hitachi Aloka,
Tokyo, Japan) at 48-mm slices. Regions of interest were centered on the cylindrical
defect area and analyzed by image-analyzing software AZE VirtualPlace (AZE,
Ltd, Tokyo, Japan). The bone growth was measured as bone volume (BV) per
tissue volume (TV). Subsequently, the femoral condyle was fixed in 4%
paraformaldehyde, decalcified in 10% EDTA, embedded in paraffin, and the
sections were stained with hematoxylin and eosin and safranin O. The sections
were assessed by a histological grading scheme31, in which the defect lesion was
scored on a scale of matrix (0–4), cell distribution (0–3), surface (0–4), safranin O
stain (0–4), and percent safranin O in defect (0–4), with 19 being the best score.
For immunohistochemistry, the sections were incubated with a monoclonal
antibody to macrophages (DAKO, Glostrup, Denmark), collagen type II (Thermo
Fisher Scientific, Waltham, MA), aggrecan (Abcam, Cambridge, UK) or control
IgG (5 mg/mL) for 1 h at room temperature. The specimens were rinsed and then
incubated for 30 min with peroxidase-labeled polymer (DAKO) at room
temperature. Diaminobenzidine (DAKO) was used as a chromogen and counter
staining was performed with hematoxylin.
Quantitative real-time polymerase chain reaction (PCR). Regenerated tissues were
homogenized with ISOGEN (Nippon Gene Co., Toyama, Japan), and total RNA was
isolated according to the manufacturer’s instructions. First-strand cDNA was
synthesized from 2 mg of total RNA with oligo (dT)12–18 as primers, and the cDNAs
were used as a template for PCR. Quantitative real-time PCR was performed with
Brilliant III Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies, Santa
Clara, CA, USA) and specific primers. To validate the SYBR Green PCR products, a
dissociation step was performed to verify the Tm (annealing temperature) of the SYBR
Green PCR product after the PCRwas run. The expression levels of each mRNAwere
normalized to the expression of the housekeeping gene hypoxanthine
phosphoribosyltransferase. The primers used in this study are listed in
Supplementary Table S1.
Statistical analysis. Statistical analyses were performed using ANOVAs for multiple
samples if not otherwise specified. In some cases, Mann–Whitney U tests were used.
A P-value of ,0.05 was considered statistically significant.
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